IPO Ideas logoIPO Ideas
GMPOFSSubscription
About Us
Menu

IPO market

  • Current IPOsOpen and live issues
  • Closed IPOsPast issues and listing outcomes
  • Upcoming IPOsNew issues and opening dates
  • IPO CalendarKey dates in chronological order
GMPGrey market premium
OFSOffer for Sale
SubscriptionBid status by category

Unlisted Ideas

Invest in Pre-IPO shares

IPO Ideas

Invest in IPO in just 3 clicks

About Us
IPO Ideas

Follow us on

IPO Ideas is 100% Safe and Secure!

Your Trust, Our Priority

Empowering You with Confidence

Welcome to IPO Ideas— your trusted gateway to IPO bidding and smart investing. We're a passionate team dedicated to making equity investing simpler, faster, and more secure for everyone.

Our mission is to empower retail investors with a user-friendly platform that brings clarity, convenience, and control to the IPO process. From secure bidding to live GMP tracking and allotment updates — everything you need is just a few clicks away.

IPOs
  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Calendar
Tools
  • GMP
  • OFS
  • Subscription
Products
  • IPO Ideas
  • Unlisted Ideas
Company
  • About Us
  • Customer Service
  • Fraud Awareness
Legal
  • Privacy Policy
  • Terms & Conditions
  • Legal & Regulatory

Advertiser Disclosure

G2RS Verified under Exempt Financial Services Advertiser

We offer two types of advertising on our website: display advertisements related to brokers and IPOs, and affiliate links that redirect users to a stock broker's website.

We have partnerships with brokers, and when you become a client of a broker through our affiliate links, we may receive an affiliate commission. We do not work with individual clients after you click on affiliate links.

We do not provide tips, recommendations, or buy/sell calls. All information published on this website is for educational and knowledge sharing purposes only. Our broker reviews are completely unbiased, and the final choice remains yours.

We provide up-to-date information on IPOs, buybacks, NCDs, SGBs, and rights issues. GMP data is displayed strictly for informational and news purposes only. We do not work with or trade through GMP operators.

COPYRIGHT ©2026 IPO Ideas • All rights reserved

Aptus Pharma IPO logo

Aptus Pharma IPO

SME • BSE

Listed
Listed at
80.8
+15.43%

Aptus Pharma IPO is a SME IPO. Issue size is 13.02 Cr. Price band is ₹65 to ₹70 per share. Minimum investment is ₹2.80 L. Lot size is 2000 shares. Open from 23 Sept 2025 to 25 Sept 2025. on 26 Sept 2025. Listing on 30 Sept 2025 at BSE. Lead manager: Interactive Financial Services Ltd.. Key details for GMP, subscription, price, , and listing in one place.

Official documents:RHP
IPO detailsSubscriptionAllotmentListingPriceReviewsNews

Aptus Pharma IPO overview

Aptus Pharma IPO Key figures

Price band, lot, minimum application, and issue window at a glance.

Price band
₹65 to ₹70
Lot size
2000 shares / lot
Min investment
₹2,80,000

Aptus Pharma IPO progress

Subscription, allotment, refund, share credit, and listing milestones.

Listed
  1. Issue opens

    Subscription opens

    23 Sept 2025

  2. Issue closes

    Last day to apply

    25 Sept 2025

  3. Allotment

    Allotment status out

    26 Sept 2025

  4. Refund / Share credit

    Refund initiated · Shares in demat

    29 Sept 2025

  5. Listing

    Trading begins

    30 Sept 2025

Aptus Pharma IPO lot size

CategoryLotsSharesAmountProfit @ listing
Retail (Min)24,000₹2,80,000+₹43,200
S-HNI (Min)36,000₹4,20,000+₹64,800
S-HNI (UPI)36,000₹4,20,000+₹64,800
S-HNI (Max)714,000₹9,80,000+₹1,51,200
B-HNI (Min)816,000₹11,20,000+₹1,72,800

Profit based on the official listing price for each investor category.

Cut‑off within the price band is set after book‑building when applicable. SME issues often require at least two lots; mainboard retail typically bids one lot at cut‑off.

About Aptus Pharma IPO

From the company / RHP narrative.

Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations The company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more. Products: Aptus Pharma: Focuses on acute therapies i.e, anti-infectives, pain management, etc. Aptus CD care: Focused on chronic therapies Aptus Wellcare: Offers wellness and nutraceutical products Aptus Global: Export in overseas market As of March 31, 2025, the company has 194 pharmaceutical formulations in more than eleven therapeutic segments. Its warehouse is located over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model includes 125 direct and sub distributors and a sales team of 54 field personnel. As of March 31, 2025, the company had 70 employees. Competitive Strengths Diversified product portfolio Robust distribution network Strategic manufacturing alliances across Gujarat, Uttarakhand and Himachal Pradesh Competitive and cost-effective pricing Experienced management team

Aptus Pharma IPO Issue Objective

How the issuer plans to use IPO proceeds.

Capital Expenditure for Office Premises with furniture and Industrial Racks Working Capital General corporate purposes

Download the app

Follow the latest IPO & unlisted research on iOS and Android.

Google PlayApp Store

Documents & links

Prospectus, draft filings, and company site open in a new tab.

RHPDHRPCompany website

Issue details

Key details about the issue, including the face value, lot size, and minimum investment.

Issue Type
BB
Face Value
10
Lead Managers
  • Interactive Financial Services Ltd.
Min Quantity
4,000
Company Promoters(11)
  • Tejash Maheshch
  • ra Hathi
  • Chatrabhuj Vallabhbhai Butani
  • Kapilbhai Hasmukhbhai Ch
  • arana
  • Ghanshyam Vinubhai Pansuriya
  • Milly Chetan Lalseta
  • Riddhish Natwarlal Tanna
  • Gaurang Rameshch
  • ra Thakker
  • Kripaliben Mayank Thakker And Kunjal Piyushbhai Unadkat
Website
https://aptus-pharma.com/
Email
info@aptuspharma.com
Phone
+91 76004 27827
Address
Aptus Pharma Ltd. Ashutosh Buildcon, Opp. Slok - 2, Nr. Harikrupa Logistic Park, Aslali, Ahmedabad, Daskroi, Ahmedabad, Gujarat, 382427

Financial performance

Figures from the IPO financial table (₹ Cr). Switch metric to compare years.

Aptus Pharma IPO

Loading chart…

Aptus Pharma IPO Ratings & reviews

Community ratings and reviews — not financial advice.

No ratings yet — be the first to share your experience.

Aptus Pharma IPO FAQs

A quick overview of key terms, dates, and how to track this IPO.

What is Aptus Pharma IPO?

Aptus Pharma IPO is a public issue where the company offers its shares to investors through the stock , allowing retail, HNI, and institutional participation.

What is the IPO price band of Aptus Pharma IPO?

The IPO price band of Aptus Pharma IPO is ₹₹65 to ₹70 per share, as mentioned in the issue details.

What is the minimum investment required for Aptus Pharma IPO?

The minimum investment in Aptus Pharma IPO is ₹2,80,000, based on the applicable lot size for retail investors.

What is the lot size of Aptus Pharma IPO?

The lot size of Aptus Pharma IPO is 2000 shares per lot, and applications must be made in multiples of this lot size.

What are the opening and closing dates of Aptus Pharma IPO?

Aptus Pharma IPO opens on 23 Sept 2025 and closes on 25 Sept 2025, as per the announced schedule.

What is Aptus Pharma IPO subscription status?

Aptus Pharma IPO subscription status shows the level of demand across retail, HNI, and institutional investor categories during the issue period.

What is Aptus Pharma IPO GMP today?

Aptus Pharma IPO GMP (Grey Market Premium) today is around ₹TBA, reflecting current grey market activity before listing.

Is Aptus Pharma IPO GMP positive or negative?

Aptus Pharma IPO GMP is currently subject to change, based on prevailing grey market trends. GMP may change over time.

What does Aptus Pharma IPO GMP indicate for listing?

A positive Aptus Pharma IPO GMP may indicate market interest ahead of listing, while actual listing performance depends on subscription response and market conditions.

When is Aptus Pharma IPO listing date?

The expected listing date of Aptus Pharma IPO is 30 Sept 2025, subject to completion of the process.

Where can I check Aptus Pharma IPO allotment status?

Aptus Pharma IPO status can be checked online once the process is completed using application or PAN details.

Can Aptus Pharma IPO subscription and GMP change before listing?

Yes, Aptus Pharma IPO subscription figures and GMP may change during the issue period and before listing based on market activity.